Presentation Terence FlynnEquity Analyst Great. Good morning, everybody. I'm Terence Flynn, Morgan Stanley's U.S. biopharma analyst, and I'm very pleased to be hosting Regeneron to kick off our 23rd Annual Global Healthcare Conference this morning. For important disclosures, please see the Morgan Stanley research disclosure website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative. Today from the company, we have Len Schle ...